Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Lacedonia, G. Valerio, G. P. Palladino, M. Correale, G. E. Carpagnano, M. di Biase, M. P. Foschino Barbaro (Foggia, Italy). Pulmonary hypertension and COPD: Clinical assessment and biomarkers. Eur Respir J 2013; 42: Suppl. 57, 2653

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension Source: International Congress 2014 – Comorbidities Year: 2014 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 NT-proBNP in assessment of pulmonary hypertension in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013 Pulmonary vessels remodeling in COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Comparison pulmonary rehabilitation efficiency in COPD patients between with and without pulmonary hypertension Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Pulmonary hypertension in COPD: Prevalence and characteristics Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Phosphodiesterase inhibitors as promising therapies for cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators Source: International Congress 2014 – Clinical presentations Year: 2014 Diabetes mellitus and obstructive pulmonary disease. Is there an association? Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Pulmonary hypertension in a COPD Patient Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020